Skip to main content
Contact Us
Subscribe
E-Edition
57°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about EDIT
Recent news which mentions EDIT
< Previous
1
2
3
4
5
6
7
Next >
Gene Therapy Could Be On the Cusp of a Major Breakthrough, but Investors May Have to Remain Patient
October 30, 2023
Tickers
AMGN
BLUE
CRSP
EDIT
Tags
EDIT
Market News
Recent Press Releases
From
Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023
October 24, 2023
Tickers
ABNB
ALKS
AMZN
ANL
Tags
TTD
CRTO
MKFG
From
Benzinga
3 Gene Editing Stocks to Generate Super-Charged Gains
October 18, 2023
Tickers
BEAM
CRSP
EDIT
GNOM
Tags
GNOM
VRTX
NASDAQ:EDIT,NASDAQ:CRSP,NASDAQ:GNOM,NASDAQ:VRTX,NASDAQ:SRPT,NASDAQ:NTLA,NASDAQ:BEAM
From
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2023
October 18, 2023
Tickers
ALB
ALPN
ARM
BIP
Tags
ESTC
SHW
HPP
From
Benzinga
1 Risky Biotech Stock to Consider Buying, and 1 to Avoid
October 18, 2023
Tickers
BEAM
EDIT
Tags
Market News
Recent Press Releases
EDIT
From
Motley Fool
Analyst Ratings for Editas Medicine
October 18, 2023
Tickers
EDIT
Tags
EDIT
Market News
BZI/AAR
From
Benzinga
Editas Medicine Has To Navigate Sickle Cell Therapy Competition: Analyst
October 17, 2023
Tickers
BLUE
CRSP
EDIT
Tags
Penny Stocks
Small Cap
Analyst Ratings
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2023
October 17, 2023
Tickers
ACA
ACAD
ACDC
ACLX
Tags
GFL
WHD
ALKS
From
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
October 17, 2023
Tickers
AHG
AMAM
ARDX
EDIT
Tags
NOK
CALTNYSE
MNTS
From
InvestorPlace
NetScout Systems, Ericsson And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
October 17, 2023
Tickers
AMAM
EDIT
ERIC
NOK
Tags
Pre/Market Outlook
Trading Ideas
Small Cap
From
Benzinga
Is Editas Stock a Buy Now?
October 07, 2023
Tickers
EDIT
Tags
Recent Press Releases
Market News
EDIT
From
Motley Fool
Avoid Big Losses With Biotech Stocks by Paying Attention to These 2 Things
October 05, 2023
Tickers
EDIT
Tags
EDIT
Market News
Recent Press Releases
From
Motley Fool
Better Gene Editing Stock: Editas Medicine vs. CRISPR Therapeutics
October 02, 2023
Tickers
CRSP
EDIT
Tags
Recent Press Releases
Market News
EDIT
From
Motley Fool
Why SeaStar Medical Holding Shares Are Trading Higher By Around 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
September 29, 2023
Tickers
ADD
APRN
ASTI
BCLI
Tags
BTTX
GPCR
VRAR
From
Benzinga
Editas Medicine Is Beyond Skepticism, Analyst Has Confidence In Sickle Cell Therapy, Upgrades Stock
September 29, 2023
Tickers
CRSP
EDIT
Tags
Health Care
Expert Ideas
General
From
Benzinga
Why Editas Medicine Stock Is Soaring Today
September 29, 2023
Tickers
CRSP
EDIT
SF
VRTX
Tags
SF
CRSP
Market News
From
Motley Fool
Expert Ratings for Editas Medicine
September 29, 2023
Tickers
EDIT
Tags
Analyst Ratings
BZI/AAR
Benzinga
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023
September 29, 2023
Tickers
ABBV
ADBE
ADSK
AKAM
Tags
AMH
AKAM
Downgrades
From
Benzinga
Nike To Rally Around 53%? Here Are 10 Other Analyst Forecasts For Friday
September 29, 2023
Tickers
ACN
DPZ
EDIT
FEMY
Tags
Analyst Ratings
ACN
DPZ
From
Benzinga
Nike, OPKO Health And Other Big Stocks Moving Higher In Friday's Pre-Market Session
September 29, 2023
Tickers
BMBL
BROG
EDIT
FOLD
Tags
Benzinga
Movers
NVGS
From
Benzinga
Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
September 25, 2023
Tickers
AA
AGRI
ALEC
AVTX
Tags
FAZE
Top Gainers
EDIT
From
Benzinga
1 Gene Editing Stock to Buy Now, and 1 to Sell
September 23, 2023
Tickers
CRBU
EDIT
Tags
CRBU
Market News
Recent Press Releases
From
Motley Fool
Analyst Expectations for Editas Medicine's Future
August 29, 2023
Tickers
EDIT
Tags
Benzinga
Analyst Ratings
BZI/AAR
From
Benzinga
These 2 Stocks Could Skyrocket by 54% and 119%, According to Wall Street
August 23, 2023
Tickers
EDIT
NTLA
Tags
EDIT
Market News
Recent Press Releases
From
Motley Fool
Expert Ratings for Editas Medicine
August 03, 2023
Tickers
EDIT
Tags
Benzinga
BZI/AAR
Analyst Ratings
From
Benzinga
This 1 Problem Could Sink at Least 4 Gene-Editing Stocks
June 29, 2023
Tickers
BLUE
CRSP
EDIT
NTLA
Tags
NTLA
Recent Press Releases
Market News
From
Motley Fool
Is Editas Medicine Stock a Buy Now?
June 28, 2023
Tickers
EDIT
Tags
EDIT
Market News
Recent Press Releases
From
Motley Fool
After It Fell 15% in 1 Day, Should You Buy The Dip on Editas Stock?
June 20, 2023
Tickers
EDIT
Tags
EDIT
Market News
Recent Press Releases
From
Motley Fool
Why John Wiley & Sons Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 15, 2023
Tickers
ALDX
AXLA
BBLG
BENF
Tags
GT
ONCS
JFBR
From
Benzinga
2 Short-Squeeze Candidates That Could Go Parabolic
June 15, 2023
Tickers
BLUE
CRSP
EDIT
NTLA
Tags
NTLA
Recent Press Releases
Market News
From
Motley Fool
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.